Restore Medical LTD Secures $23M to Advance Breakthrough Medical Device for Heart Failure Therapy

Restore Medical LTD secures $23M to Advance Breakthrough Medical Device for Heart Failure Therapy

Restore Medical secures $23M for heart failure studies

Restore Medical, a medtech company focusing on heart failure therapies, announced the closing of a $23 million Series B funding round.Pitango HealthTech co-led the round with the European Innovation Council (EIC) Fund with participation from existing investors, including Peregrine Ventures. WHAT IT DOES Restore Medical treats heart failure with transcatheter therapies designed to restore hemodynamic balance and improve clinical outcomes.  The co…

HeartBeat.bio and biotx.ai Sign License and Technology Access Agreement to Identify Novel Targets in Heart Failure

HeartBeat.bio AG and biotx.ai GmbH announced a strategic partnership to identify and validate novel therapeutic targets in heart failure. The collaboration combines biotx.ai’s causal mapping of the genome for target discovery with HeartBeat.bio’s human-based Cardioid Drug Discovery Platform to drive innovation in heart failure drug development. [HeartBeat.bio (Biotech Newswire)] Press Release

Israeli transcatheter co Restore Medical raises $23m

The company's transcatheter approach introduces a new minimally invasive therapeutic option for heart failure patients who have limited effective treatments today.